{"entity":{"type":"insider","cik":"0001439275","url":"/insider/0001439275","json_url":"/insider/0001439275.json","name":"LeBel Carl","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":14,"n_filings":8,"first":"2015-09-22","last":"2022-07-07","span_basis":"filed_date"},"name_variants":[{"name":"LeBel Carl","source":"filing","n_filings":8,"first_seen":"2015-09-22","last_seen":"2022-07-07"}],"transactions":[{"id":6638444,"accession":"0001127602-22-019045","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-019045","line_url":"/filing/0001127602-22-019045#line-2","is_derivative":false,"issuer_cik":"0001439275","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001439275","owner_cik":"0001439275","owner_name":"LeBel Carl","owner_display_name":"LeBel Carl","owner_url":"/insider/0001439275","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4421.0,"shares_display":"4,421","price_per_share":1.52,"price_display":"1.52","price_state":"stated","total_value":6719.92,"total_display":"6,719.92","total_whole":"6,720","shares_owned_after":26343.0,"shares_owned_after_display":"26,343","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-07-06","filed_date":"2022-07-07","scope":"insider"},{"id":6462977,"accession":"0001127602-22-006321","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-006321","line_url":"/filing/0001127602-22-006321#line-2","is_derivative":false,"issuer_cik":"0001439275","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001439275","owner_cik":"0001439275","owner_name":"LeBel Carl","owner_display_name":"LeBel Carl","owner_url":"/insider/0001439275","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1069.0,"shares_display":"1,069","price_per_share":3.529,"price_display":"3.53","price_state":"stated","total_value":3772.501,"total_display":"3,772.50","total_whole":"3,773","shares_owned_after":11126.0,"shares_owned_after_display":"11,126","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-22","filed_date":"2022-02-23","scope":"insider"},{"id":6462975,"accession":"0001127602-22-006321","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-006321","line_url":"/filing/0001127602-22-006321#line-1","is_derivative":false,"issuer_cik":"0001439275","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001439275","owner_cik":"0001439275","owner_name":"LeBel Carl","owner_display_name":"LeBel Carl","owner_url":"/insider/0001439275","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":974.0,"shares_display":"974","price_per_share":3.873,"price_display":"3.87","price_state":"stated","total_value":3772.302,"total_display":"3,772.30","total_whole":"3,772","shares_owned_after":12195.0,"shares_owned_after_display":"12,195","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-18","filed_date":"2022-02-23","scope":"insider"},{"id":6404639,"accession":"0001127602-22-005750","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-005750","line_url":"/filing/0001127602-22-005750#line-2","is_derivative":false,"issuer_cik":"0001439275","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001439275","owner_cik":"0001439275","owner_name":"LeBel Carl","owner_display_name":"LeBel Carl","owner_url":"/insider/0001439275","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":901.0,"shares_display":"901","price_per_share":4.189,"price_display":"4.19","price_state":"stated","total_value":3774.289,"total_display":"3,774.29","total_whole":"3,774","shares_owned_after":13169.0,"shares_owned_after_display":"13,169","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-17","filed_date":"2022-02-18","scope":"insider"},{"id":6404636,"accession":"0001127602-22-005750","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001127602-22-005750","line_url":"/filing/0001127602-22-005750#line-1","is_derivative":false,"issuer_cik":"0001439275","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001439275","owner_cik":"0001439275","owner_name":"LeBel Carl","owner_display_name":"LeBel Carl","owner_url":"/insider/0001439275","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":831.0,"shares_display":"831","price_per_share":4.429,"price_display":"4.43","price_state":"stated","total_value":3680.499,"total_display":"3,680.50","total_whole":"3,680","shares_owned_after":14070.0,"shares_owned_after_display":"14,070","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-16","filed_date":"2022-02-18","scope":"insider"},{"id":6991700,"accession":"0001127602-22-005336","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001127602-22-005336","line_url":"/filing/0001127602-22-005336#line-2","is_derivative":false,"issuer_cik":"0001439275","issuer_name":"Frequency Therapeutics, Inc.","issuer_ticker":"FREQ","issuer_name_source":null,"issuer_url":"/issuer/0001439275","owner_cik":"0001439275","owner_name":"LeBel Carl","owner_display_name":"LeBel Carl","owner_url":"/insider/0001439275","role":"Officer (Chief Development Officer)","role_mark":"O","role_mark_label":"Officer (Chief Development Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Development Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":844.0,"shares_display":"844","price_per_share":4.331,"price_display":"4.33","price_state":"stated","total_value":3655.364,"total_display":"3,655.36","total_whole":"3,655","shares_owned_after":14901.0,"shares_owned_after_display":"14,901","ownership_form":"D","is_10b5_1":null,"transaction_date":"2022-02-15","filed_date":"2022-02-16","scope":"insider"},{"id":2479391,"accession":"0001209191-16-151770","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-16-151770","line_url":"/filing/0001209191-16-151770#line-5","is_derivative":false,"issuer_cik":"0001439275","issuer_name":"Otonomy, Inc.","issuer_ticker":"OTIC","issuer_name_source":null,"issuer_url":"/issuer/0001439275","owner_cik":"0001439275","owner_name":"LeBel Carl","owner_display_name":"LeBel Carl","owner_url":"/insider/0001439275","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":1456.0,"shares_display":"1,456","price_per_share":18.065,"price_display":"18.06","price_state":"stated","total_value":26302.64,"total_display":"26,302.64","total_whole":"26,303","shares_owned_after":9458.0,"shares_owned_after_display":"9,458","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-21","filed_date":"2016-11-22","scope":"insider"},{"id":2479373,"accession":"0001209191-16-151770","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-16-151770","line_url":"/filing/0001209191-16-151770#line-3","is_derivative":false,"issuer_cik":"0001439275","issuer_name":"Otonomy, Inc.","issuer_ticker":"OTIC","issuer_name_source":null,"issuer_url":"/issuer/0001439275","owner_cik":"0001439275","owner_name":"LeBel Carl","owner_display_name":"LeBel Carl","owner_url":"/insider/0001439275","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9169.0,"shares_display":"9,169","price_per_share":18.0721,"price_display":"18.07","price_state":"stated","total_value":165703.0849,"total_display":"165,703.08","total_whole":"165,703","shares_owned_after":9458.0,"shares_owned_after_display":"9,458","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-11-18","filed_date":"2016-11-22","scope":"insider"},{"id":2595863,"accession":"0001209191-16-140652","txn_seq":8,"anchor":"line-8","filing_url":"/filing/0001209191-16-140652","line_url":"/filing/0001209191-16-140652","is_derivative":false,"issuer_cik":"0001439275","issuer_name":"Otonomy, Inc.","issuer_ticker":"OTIC","issuer_name_source":null,"issuer_url":"/issuer/0001439275","owner_cik":"0001439275","owner_name":"LeBel Carl","owner_display_name":"LeBel Carl","owner_url":"/insider/0001439275","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21250.0,"shares_display":"21,250","price_per_share":17.95,"price_display":"17.95","price_state":"stated","total_value":381437.5,"total_display":"381,437.50","total_whole":"381,438","shares_owned_after":18575.0,"shares_owned_after_display":"18,575","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-09-06","filed_date":"2016-09-08","scope":"insider","n_lines":3},{"id":8502281,"accession":"0001209191-15-086708","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-15-086708","line_url":"/filing/0001209191-15-086708","is_derivative":false,"issuer_cik":"0001439275","issuer_name":"Otonomy, Inc.","issuer_ticker":"OTIC","issuer_name_source":null,"issuer_url":"/issuer/0001439275","owner_cik":"0001439275","owner_name":"LeBel Carl","owner_display_name":"LeBel Carl","owner_url":"/insider/0001439275","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21250.0,"shares_display":"21,250","price_per_share":28.03892028235294,"price_display":"28.04","price_state":"stated","total_value":595827.056,"total_display":"595,827.06","total_whole":"595,827","shares_owned_after":16981.0,"shares_owned_after_display":"16,981","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-12-21","filed_date":"2015-12-22","scope":"insider","n_lines":2},{"id":8793934,"accession":"0001209191-15-071918","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-15-071918","line_url":"/filing/0001209191-15-071918#line-3","is_derivative":false,"issuer_cik":"0001439275","issuer_name":"Otonomy, Inc.","issuer_ticker":"OTIC","issuer_name_source":null,"issuer_url":"/issuer/0001439275","owner_cik":"0001439275","owner_name":"LeBel Carl","owner_display_name":"LeBel Carl","owner_url":"/insider/0001439275","role":"Officer (Chief Scientific Officer)","role_mark":"O","role_mark_label":"Officer (Chief Scientific Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Scientific Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21250.0,"shares_display":"21,250","price_per_share":24.3565,"price_display":"24.36","price_state":"stated","total_value":517575.625,"total_display":"517,575.62","total_whole":"517,576","shares_owned_after":8920.0,"shares_owned_after_display":"8,920","ownership_form":"D","is_10b5_1":null,"transaction_date":"2015-09-21","filed_date":"2015-09-22","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":14,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":0,"open_market":true},{"code":"S","label":"Open-market sale","n":14,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":14},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001703647","name":"Frequency Therapeutics, Inc.","url":"/issuer/0001703647","role":"Officer (Chief Development Officer)","n_filings":4,"first_seen":"2022-02-16","last_seen":"2022-07-07"},{"type":"issuer","type_label":"ISSUER","cik":"0001493566","name":"Otonomy, Inc.","url":"/issuer/0001493566","role":"Officer (Chief Scientific Officer)","n_filings":4,"first_seen":"2015-09-22","last_seen":"2016-11-22"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001439275","retrieved_at":"2026-08-23T17:14:30+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}